215183-27-0

Basic information

• Product Name: TERT-BUTYL N-[(5-BROMO-2-THIENYL)METHYL]CARBAMATE
• Synonyms: TERT-BUTYL N-[(5-BROMO-2-THIENYL)METHYL]CARBAMATE;(5-BROMO-THIOPHEN-2-YLMETHYL)-CARBAMIC ACID TERT-BUTYL ESTER;tert-butyl (5-bromothiophen-2-yl)methylcarbamate;2-[(Boc-amino)methyl]-5-bromothiophene;N-Boc-5-bromothiophene-2-methylamine;N-Boc-5-bromothiophen-2-methanamine
• CAS NO: 215183-27-0
• Molecular Formula: C₁₀H₁₄BrNO₂S
• Molecular Weight: 292.19
• Mol File: 215183-27-0.mol
• Article Data: 1

Chemical Properties

• Melting Point: 51 °C
• Boiling Point: 371 °C at 760 mmHg
• Flash Point: >110℃
• Appearance: /
• Density: 1.416 g/cm³
• Vapor Pressure: 1.06E-05mmHg at 25°C
• Refractive Index: 1.55
• CAS DataBase Reference: TERT-BUTYL N-[(5-BROMO-2-THIENYL)METHYL]CARBAMATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL N-[(5-BROMO-2-THIENYL)METHYL]CARBAMATE(215183-27-0)
• EPA Substance Registry System: TERT-BUTYL N-[(5-BROMO-2-THIENYL)METHYL]CARBAMATE(215183-27-0)

Safety Data

• Hazard Codes: Xn
• Statements: 22
• Safety Statements: S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.; S37/39:Wear suitable g
• WGK Germany: 3
• Hazardous Substances Data: 215183-27-0(Hazardous Substances Data)

Usage

General Description

TERT-BUTYL N-[(5-BROMO-2-THIENYL)METHYL]CARBAMATE is a chemical compound with the molecular formula C11H14BrNO2S. It is a carbamate derivative with a tert-butyl group attached to the nitrogen atom and a thienylmethyl group attached to the carbamate nitrogen atom. TERT-BUTYL N-[(5-BROMO-2-THIENYL)METHYL]CARBAMATE is commonly used in organic synthesis and pharmaceutical research as a reagent or intermediate in the production of various pharmaceuticals and agrochemicals. It is also known for its potential as a pesticide or agrochemical due to its ability to inhibit the growth of certain pests or pathogens. The compound is typically handled and stored in a controlled environment under strict safety protocols due to its potential hazards and reactivity.

InChI:InChI=1/C10H14BrNO2S/c1-10(2,3)14-9(13)12-6-7-4-5-8(11)15-7/h4-5H,6H2,1-3H3,(H,12,13)

Upstream product

• 612499-04-4 (5-bromothiophen-2-yl) methanamine 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 612499-04-4 (5-bromothiophen-2-yl) methanamine 
• 871714-03-3 C₁₇H₂₀ClNO₂S 
• 214964-49-5 2-(2-tert-butoxycarbonylaminomethylthiophen-5-yl)carbonyl-4-chloroaniline 
• 871714-05-5 C₂₀H₂₀ClNO₇S 
• 1454904-01-8 2,2-dichloro-N-((1R,2S)-3-fluoro-1-hydroxy-1-(4-(5-(methylsulfonamidomethyl)thiophen-2-yl)phenyl)propan-2-yl)acetamide 
• 1454904-00-7 N-((1R,2S)-1-(4-(5-(aminomethyl)thiophen-2-yl)phenyl)-3-fluoro-1-hydroxypropan-2-yl)-2,2-dichloroacetamide 
• 1001414-56-7 (5-bromo-2-thienyl)methanamine hydrochloride 

Relevant articles and documents

Oxazolidinone compounds and its use in medicine

The invention relates to an oxazolidinone compound and an application thereof to preparation of drugs for preventing and treating thromboembolic diseases and in particular relates to a compound shown in a general formula (I) in the specification or stereoisomers, geometrical isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites and pharmaceutically acceptable salts or prodrugs of the compound. All the variables are defined in the specification. The invention also relates to an application of the compound shown in the general formula (I) or the stereoisomers, geometrical isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites and pharmaceutically acceptable salts or prodrugs of the compound as drugs and in particular relates to an application of the substances as drugs for preventing and treating thromboembolic diseases.